Catalyst Wire Dossier Catalyst Wire Dossier

Actos (pioglitazone)

pioglitazone · Takeda Pharmaceutical Company Limited
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Actos (pioglitazone), covering 2007-03-01 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus [Phase 2]

See pricing